Skip to main content
. 2019 Feb 18;6(2):436–445. doi: 10.1002/ehf2.12420

Table 1.

P/LP mutations associated with cardiomyopathy found in the FinHCM Genetic Study (n = 382)

Gene Nucleotide change Amino acid change No. of patients with variant, n (%) Class (ClinVar) Allele count in Finns (gnomAD) Allele count in European (non‐Finnish) (gnomAD)
GLA c.658C>T p.Arg220Ter 1 P NA NA
c.1228A>G p.Thr410Ala 1 P NA NA
MYBPC3 c.655‐2A>Ca 3 NAb NA NA
c.927‐2A>G 1 P 0/3494 1/14 966
c.1227‐13G>Aa 3 LP NA NA
c.1358dupC p.Val454fs 1 P/LP NA NA
c.1505_1509delGGTTC p.Arg502fs 3 LP NA NA
c.1575T>G p.Tyr525Ter 2 P/LP NA NA
c.2373dupG p.Trp792Valfs 4 P 0/17 280 3/67 494
c.2556_2557delCGinsTCTa , c p.Gly853Leufs 4 P NA NA
c.3181C>Ta p.Gln1061Ter 43 (11.3) P 3/16 578 0/126 472
c.3190+5G>A 5 P/LP 0/12 874 2/111 318
c.3296_3297delGG; c.3295dupG p.Gly1099fs/p.Tyr1100fs 1 P/LP 3/19 554 0/94 384
MYH7 c.1178C>T p.Ala393Val 1 LP NA NA
c.1816G>A p.Val606Met 10 (2.6) P/LP 0/3492 1/14 998
c.1987C>T p.Arg663Cys 1 P/LP NA NA
c.2155C>Ta p.Arg719Trp 1 P 0/3492 1/14 998
c.2207T>C p.Ile736Thr 1 P NA NA
c.2539_2541delAAG p.Lys847Del 2 LP NA NA
c.2770G>A p.Glu924Lys 2 P/LP NA NA
c.3158G>Aa p.Arg1053Gln 30 (7.9) LP 17/25 794 0/126 704
MYL2 c.173G>A p.Arg58Gln 1 P/LP 2/22 298 0/111 682
PRKAG2 c.905G>A p.Arg302Gln 1 P NA NA
TPM1 c.523G>Aa p.Asp175Asn 24 (6.3) P 4/25 748 1/126 700
Total 146 (38.2)

LP, likely pathogenic; NA, data not available; P, pathogenic.

a

Variant has been reported in our previous studies.

b

Variant was considered as a disease‐causing mutation in our previous21 and present study.

c

Variant was denoted A851InsT in our previous study.7